Follow The Filings

VHC VirnetX

VirnetX earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -1.20 —
Rev — — —

Insider trades

Open-market buys and sales by VHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VHC insider trades
  • None no insider bought on the open market
  • $56K sold by 2 insiders outside a trading plan
  • $489K sold by 3 insiders under 10b5-1 plans
  1. Michael F Angelo Director
    Planned sale
    $10K 1,000 shares at $10.26 3.4% of stake
    Traded Sep 30 Filed Oct 2
  2. Kendall Larsen CEO
    Planned sale
    $232K 20,425 shares at $11.37 5.7% of stake
    Traded Sep 10–14 Filed Sep 14
  3. Gary Feiner Director
    Planned sale
    $83K 7,500 shares at $11.09 31% of stake
    Traded Aug 31–Sep 1 Filed Sep 2
  4. Kendall Larsen CEO
    Planned sale
    $163K 14,575 shares at $11.22 3.9% of stake
    Traded Aug 31–Sep 2 Filed Sep 2
  5. Gary Feiner Director
    Sale
    $43K 1,875 shares at $22.70 10% of stake
    Traded Nov 26, 2025 Filed Nov 26, 2025
  6. Michael F Angelo Director
    Sale
    $13K 625 shares at $20.89 2.8% of stake
    Traded Nov 24, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 4 stock grants, 1 share withholding for taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
424B5
8-K 1.01,9.01
10-Q
8-K 5.02,5.07,9.01
10-Q
DEF 14A
DEFA14A
10-K
SCHEDULE 13D/A —
10-Q
8-K 7.01,9.01
8-K 3.01,7.01,9.01
10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
8-K 5.07
10-Q
DEF 14A
DEFA14A
10-K
SC 13D/A SC13D/A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.